Research in cats has identified the bacterium Bordetella bronchiseptica, as a primary cause of feline upper respiratory tract disease, particularly those in multicat environments including boarding and breeding catteries and rescue shelters. In addition, contact with dogs will increase the risk of this infection.
Lyophilisate: Off-white or cream-coloured pellet
Solvent: clear colourless solution
106.3-108.3 colony forming units (CFU) of live Bordetella bronchiseptica bacteria strain B-C2
Indications for use
Nobivac Bb for Cats is licensed for the active immunisation of cats, of 1 month of age or older; to reduce clinical signs of Bordetella bronchiseptica associated upper respiratory tract disease.
APET-plastic tray containing 5 single dose vials with 5 vials of solvent.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018